Cucovici Aliona, Fontana Andrea, Ivashynka Andrei, Russo Sergio, Renna Valentina, Mazzini Letizia, Gagliardi Ileana, Mandrioli Jessica, Martinelli Ilaria, Lisnic Vitalie, Muresanu Dafin Fior, Zarrelli Michele, Copetti Massimiliano, Leone Maurizio A
Department of Medical and Surgical Sciences, University of Foggia, 71122 Foggia, Italy.
Neurology Unit, Fondazione IRCCS Casa Sollievo della Sofferenza, 71013 San Giovanni Rotondo, Italy.
Life (Basel). 2021 Apr 17;11(4):352. doi: 10.3390/life11040352.
Background-Amyotrophic lateral sclerosis (ALS) is a devastating and untreatable motor neuron disease; smoking and alcohol drinking may impact its progression rate. Objective-To ascertain the influence of smoking and alcohol consumption on ALS progression rates. Methods-Cross-sectional multicenter study, including 241 consecutive patients (145 males); mean age at onset was 59.9 ± 11.8 years. Cigarette smoking and alcohol consumption data were collected at recruitment through a validated questionnaire. Patients were categorized into three groups according to ΔFS (derived from the ALS Functional Rating Scale-Revised and disease duration from onset): slow ( = 81), intermediate (80), and fast progressors (80). Results-Current smokers accounted for 44 (18.3%) of the participants, former smokers accounted for 10 (4.1%), and non-smokers accounted for 187 (77.6%). The age of ALS onset was lower in current smokers than non-smokers, and the ΔFS was slightly, although not significantly, higher for smokers of >14 cigarettes/day. Current alcohol drinkers accounted for 147 (61.0%) of the participants, former drinkers accounted for 5 (2.1%), and non-drinkers accounted for 89 (36.9%). The log(ΔFS) was weakly correlated only with the duration of alcohol consumption ( = 0.028), but not with the mean number of drinks/day or the drink-years. Conclusions: This cross-sectional multicenter study suggested a possible minor role for smoking in worsening disease progression. A possible interaction with alcohol drinking was suggested.
背景——肌萎缩侧索硬化症(ALS)是一种毁灭性的、无法治愈的运动神经元疾病;吸烟和饮酒可能会影响其进展速度。目的——确定吸烟和饮酒对ALS进展速度的影响。方法——横断面多中心研究,纳入241例连续患者(145例男性);发病时的平均年龄为59.9±11.8岁。在招募时通过经过验证的问卷收集吸烟和饮酒数据。根据ΔFS(源自修订的ALS功能评定量表和发病后的病程)将患者分为三组:进展缓慢组(ΔFS≤81)、进展中等组(ΔFS为80)和进展快速组(ΔFS>80)。结果——当前吸烟者占参与者的44例(18.3%),既往吸烟者占10例(4.1%),不吸烟者占187例(77.6%)。当前吸烟者的ALS发病年龄低于不吸烟者,且每天吸烟超过14支的吸烟者的ΔFS略高,尽管差异无统计学意义。当前饮酒者占参与者的147例(61.0%),既往饮酒者占5例(2.1%),不饮酒者占89例(36.9%)。log(ΔFS)仅与饮酒持续时间呈弱相关(r = 0.028),但与每天饮酒的平均量或饮酒年限无关。结论:这项横断面多中心研究表明吸烟在疾病进展恶化中可能起较小作用。提示可能与饮酒存在相互作用。